The stock of Sotera Health Co (SHC) has gone up by 4.56% for the week, with a 14.39% rise in the past month and a 41.12% rise in the past quarter. The volatility ratio for the week is 2.72%, and the volatility levels for the past 30 days are 4.01% for SHC. The simple moving average for the past 20 days is 6.74% for SHC’s stock, with a 15.46% simple moving average for the past 200 days.
Is It Worth Investing in Sotera Health Co (NASDAQ: SHC) Right Now?
The price-to-earnings ratio for Sotera Health Co (NASDAQ: SHC) is 111.21x, which is above its average ratio. Moreover, the 36-month beta value for SHC is 2.07. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 3 as “overweight,” 3 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SHC is 126.59M and currently, short sellers hold a 8.18% of that float. On August 27, 2024, SHC’s average trading volume was 1.05M shares.
SHC) stock’s latest price update
The stock of Sotera Health Co (NASDAQ: SHC) has decreased by -0.26 when compared to last closing price of 15.62.Despite this, the company has seen a gain of 4.56% in its stock price over the last five trading days. seekingalpha.com reported 2024-08-05 that Sotera Health Company (NASDAQ:SHC ) Q2 2024 Earnings Conference Call August 5, 2024 9:00 AM ET Company Participants Jason Peterson – VP & Treasurer Michael Petras – Chairman & CEO Jonathan Lyons – SVP & CFO Conference Call Participants Dave Windley – Jefferies Brett Fishbin – KeyBanc Capital Markets Patrick Donnelly – Citigroup Inc. Casey Woodring – J.P. Morgan Chase Salem Salem – Barclays Jason Bednar – Piper Sandler Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Second Quarter 2024 Conference Call.
Analysts’ Opinion of SHC
Many brokerage firms have already submitted their reports for SHC stocks, with Piper Sandler repeating the rating for SHC by listing it as a “Neutral.” The predicted price for SHC in the upcoming period, according to Piper Sandler is $13 based on the research report published on May 21, 2024 of the current year 2024.
Citigroup, on the other hand, stated in their research note that they expect to see SHC reach a price target of $16, previously predicting the price at $18. The rating they have provided for SHC stocks is “Buy” according to the report published on April 03rd, 2024.
Jefferies gave a rating of “Buy” to SHC, setting the target price at $15.50 in the report published on March 25th of the current year.
SHC Trading at 17.76% from the 50-Day Moving Average
After a stumble in the market that brought SHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.67% of loss for the given period.
Volatility was left at 4.01%, however, over the last 30 days, the volatility rate increased by 2.72%, as shares surge +14.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +33.99% upper at present.
During the last 5 trading sessions, SHC rose by +4.23%, which changed the moving average for the period of 200-days by +18.10% in comparison to the 20-day moving average, which settled at $14.69. In addition, Sotera Health Co saw -7.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SHC starting from WARBURG PINCUS & CO., who sale 16,594,363 shares at the price of $14.31 back on Mar 04 ’24. After this action, WARBURG PINCUS & CO. now owns 88,822,952 shares of Sotera Health Co, valued at $237,423,849 using the latest closing price.
WARBURG PINCUS & CO., the Director of Sotera Health Co, sale 16,594,363 shares at $14.31 during a trade that took place back on Mar 04 ’24, which means that WARBURG PINCUS & CO. is holding 88,822,952 shares at $237,423,849 based on the most recent closing price.
Stock Fundamentals for SHC
Current profitability levels for the company are sitting at:
- 0.31 for the present operating margin
- 0.51 for the gross margin
The net margin for Sotera Health Co stands at 0.04. The total capital return value is set at 0.12. Equity return is now at value 9.48, with 1.30 for asset returns.
Based on Sotera Health Co (SHC), the company’s capital structure generated 0.84 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 5.28. The interest coverage ratio of the stock is 2.32.
Currently, EBITDA for the company is 516.81 million with net debt to EBITDA at 4.34. When we switch over and look at the enterprise to sales, we see a ratio of 5.9. The receivables turnover for the company is 6.84for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.93.
Conclusion
To wrap up, the performance of Sotera Health Co (SHC) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
